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Introductory Remarks and Objectives 
 
Over the past two decades, the medical community’s understanding of celiac disease, also 
known as gluten sensitivity, has evolved significantly. No longer just a GI problem, celiac 
disease is now recognized as a multisystem autoimmune disorder. A growing body of distinct 
neurological conditions such as cerebellar ataxia, epilepsy, myoclonic ataxia, chronic 
neuropathies, migraine headache and dementia has been reported, mainly in middle-aged adults. 
However, while much is known regarding the neuropsychiatric manifestations of celiac disease 
in the adult population, less is understood about its presentation in the pediatric population. This 
is especially true of the “soft” neurological conditions, such as headache, learning disorders, 
attention-deficit/hyperactivity disorder (ADHD), and depression.  
The aim of this paper is to briefly discuss the pathophysiology of celiac disease, describe 
what is currently known about the neuro-psychiatric manifestations of celiac disease in children, 
and discuss the potential benefits of more aggressive serologic testing. 
 
Pathophysiology of Celiac Disease 
 
Celiac disease is a unique autoimmune disorder most notably because the environmental 
precipitants (gluten, hordein, secalin) are known (1). The symptoms of the disease manifest not 
directly from the ingestion of gluten, but rather from the complex interaction between the 
gastrointestinal system, enzymatically degraded components of gluten, and the immune system 
of the individual. 
The term “prolamins” technically refers to the protein component of certain kinds of 
grain. These prolamins have a high content of the amino acids proline and glutamine. When 
referring to the prolamins relevant to those with celiac disease, the term gluten is used loosely to 
describe the protein fraction of wheat, rye and barley. This is technically incorrect because the 
prolamins of barley and rye are known as hordein and secalin, respectively. This technical 
oversite can be made because of the immunologic cross reactivity between the prolamins of 
wheat, barley and rye (2). 
The alcohol-soluble fraction of gluten is known as gliadin, while the alcohol insoluble 
fraction is known as glutenin. It is the enzymatically modified gliadin fraction, which triggers the 
immune response in individuals with celiac disease. This immune response ensues because the 
gliadin fraction is resistant to degradation by gastric, pancreatic and intestinal brush-border 
membrane proteases in the human intestine and thus remains in the intestinal lumen after gluten 
ingestion. Gliadin peptides pass through the epithelial barrier of the intestine and are engulfed by 
antigen-presenting cells (APCs) in the lamina propria. It is possible that passage of gliadin is 
facilitated by intestinal infection, which would increase gastrointestinal permeability (1). 
The inflammatory response which ensues causes the loss of villous architecture, which is the 
hallmark histologic manifestation of celiac disease on intestinal biopsy as well as the 
characteristic malabsorption, which cause many of the clinical findings of individuals with celiac 




both the innate and adaptive immune systems and results in the generation of antibodies against 
gliadin and endomysial components, specifically transglutaminase (1). 
A key to understanding celiac disease is that the elimination of gluten from the diet is 
usually sufficient to terminate the inflammatory cascade, with eventual healing of the 
gastrointestinal tract and decreased concentrations of antibodies characteristic of celiac disease. 
This is in stark contrast to other environmentally induced pathologies, in which the process of 
destruction is not reversible (e.g. radiation induced malignancy). That having been said, there are 
certain sequelae of celiac disease, which may not be reversible, inclusive of certain psychiatric 
manifestations to be more fully described later on. 
 
Diagnosis of Disease 
 
Diagnostic criteria for celiac disease vary from country to country, but the most 
frequently used criteria for diagnosis include endoscopy, serologic investigation and 
improvement of symptoms on initiation of a gluten-free diet. The term “silent or subclinical 
celiac disease” refers to individuals who deny symptoms of celiac disease but whose serology 
point to an immune response against gluten and have evidence of disease on biopsy. It is 
important to note that many of these “silent” patients often do report feeling better on a gluten-
free diet. The term “potential” celiac disease refers to those with positive serologies but benign 
histologic biopsies (3). Treatment of those with “potential” celiac disease is controversial; see 
recommendations further on in this article. 
 
Epidemiology of Celiac Disease 
 
Celiac disease is present not only in countries populated by persons of European ancestry 
but also in the Middle East, Asia, South America and North Africa. It is most prevalent among 
Caucasians and is most frequently diagnosed between the ages of 10-40. Occurrence of disease is 
estimated to be 1% of the general population and it is believed that the majority of cases remain 
undiagnosed. In the United States prevalence estimates range from 1:80 to 1:300 in children. Of 
those individuals with no risk factors or perceived symptoms, estimates of disease prevalence are 
suggested to be approximately 1:133. The ratio of asymptomatic to symptomatic cases has been 
estimated by some investigators to be as high as 7:1 (3). 
Between 8 and 10 percent of children with apparent “idiopathic” short stature have 
serological evidence of celiac disease and patients with patient with gastrointestinal symptoms 
have slightly attenuated adult height unless treated prior to puberty. Delay in linear growth may 
occur even when weight for height ratios are fairly normal, and in the absence of significant 
gastrointestinal symptoms. Thus it is likely that under nutrition cannot be completely to blame 
(3). 
Boys with untreated celiac disease are noted to have decreased levels of 
dihydrotestosterone (DHT) in their serum, in a trend suggestive of androgen resistance. 
Adolescent girls may have an increased frequency of menstrual abnormalities (e.g. delayed 
menarche) and later may have problems with infertility and experience an early menopause. 







High Risk Populations 
 
Populations particularly at high risk for celiac disease include first and second degree 
relatives of patients with celiac disease, patients with Down syndrome, patients with Turner 
syndrome, IgA deficiency, Williams syndrome, and autoimmune thyroiditis. Individuals with 
Down syndrome have the highest risk of disease, with up to 16% of the population being 
affected, a 20-fold increase over the general population. Other groups may have 2-7% affected, 
still a substantially higher incidence. Evidence and theories as to why these associations might be 
are beyond the scope of this paper. Suffice it to say that many children with chronic care needs 
will be at high risk for being diagnosed with celiac disease (3). It is worth noting however that 
there is no evidence that individuals afflicted with autism are at increased risk for celiac disease 
(4); this is despite the high popularity of gluten and casein free diets among parents caring for 
children with autism. 
 
Range of Neuropsychiatric Symptoms 
 
Celiac disease may have as its primary manifestation neuropsychiatric symptoms (3). 
Adults with celiac disease can present with symptoms such as ataxia, depression, anxiety, 
epilepsy, and headache. Children also can manifest with neuropsychiatric manifestations but in 
contrast with adults can also present with developmental delay, hypotonia, learning disorders. 
Some of these symptoms such as developmental delay and hypotonia can be attributed to 
malabsorption of specific nutrient deficiencies. These symptoms are likely the result of the 
damaged gastrointestinal mucosa and it is not surprising that such symptoms should be reversible 
upon initiation of a gluten-free diet and correction of the deficiencies (3). 
However there is evidence for other mechanisms by which the inflammatory response of 
the immune system might lead to neuropsychiatric manifestations of celiac disease. 
Hadjivassiliou et al have published extensively on the neurologic manifestations of celiac disease 
in adults and documented the existence of autoantibodies targeting transglutaminases (TG2) in 
the brain and intestinal mucosa in patients with gluten ataxia (5). These autoantibodies were 
most prevalent in the cerebellum, medulla and pons. IgA deposition and vasculitis in the 
cerebellum can explain the ataxia in many patients with celiac disease and could potentially shed 
light on other neuropsychiatric manifestations as well. 
De Santis et al first described an individual with schizophrenic symptoms who had 
evidence of cerebral hypoperfusion and celiac disease in 1997 (6). This prompted Addolorato et 
al to further investigate perfusion in patients with untreated celiac disease, treated celiac disease 
(gluten-free diet) and case controls and found those with untreated celiac disease were 
significantly more likely to have areas of cerebral hypoperfusion. He found that brain 
hypoperfusion was reversible with initiation of a gluten-free diet (7). 
While these studies looked at adult patients, the mechanisms behind the cerebral 
hypoperfusion could potentially extend to the pediatric population and explain many of the 
neuropsychiatric manifestations of celiac disease in children inclusive of depression. 
Zelnik et al found that the range of neuropsychiatric manifestations of celiac disease in the 
pediatric population was quite broad and included chronic headache, developmental delay, 
hypotonia and learning disorders or ADHD (4). In contrast with other findings, Zelnik concluded 
that only migraine headache and transient infantile hypotonia could be corrected by institution of 





Speculations Regarding the Neuropsychiatric Manifestations of Celiac Disease 
 
In looking through the rapidly growing body of evidence regarding the neuropsychiatric 
manifestations of celiac disease it is clear the much remains to be learned regarding the exact 
mechanisms by which individuals with celiac disease develop symptoms. Some symptoms can 
be explained simply by nutrient deficiency, while others are perhaps the result of a vasculitis. 
Other symptoms are perhaps the result of hypoperfusion. However, while there is still much we 
do not know, it is clear that celiac disease is not simply a disease isolated to the gastrointestinal 
system. Extra-intestinal symptoms are present in as many as 10% of those with celiac disease 
(3). Furthermore it is not known how correctable all of these manifestations will be. Therefore it 
behooves the practicing clinician to be vigilant to suspect celiac disease in patients presenting 
with neuropsychiatric symptoms, even if GI symptoms are absent or minimized by the patient. 
 
Relevance to the Pediatrician 
 
The majority of research looking into the neuropsychiatric manifestations of celiac 
disease involves adults. One should never assume that the trends in the pediatric population 
mimic that of adults. The popular slogan that children are NOT little adults rings true in regards 
to celiac disease as well. As previously stated, Zelnik et al did find many children with 
neuropsychiatric symptoms who were afflicted with celiac disease. However, a recent 
publication by Ruggieri et al found that the prevalence of neurologic/psychiatric manifestation in 
children with celiac disease was only slightly higher than that in controls (8). In their discussion 
the authors speculate that children may perhaps be protected against nervous system involvement 
either by shorter duration of illness, strict adherence to a diet free of gluten or even a changing 




In reviewing the literature in preparation for this paper it seems clear to this writer that 
many with  positive serologies suggestive of celiac disease may not be aware of any 
gastrointestinal symptoms (indeed there may be none). It is also evident that those with celiac 
disease on a gluten-free diet may not be as adherent as their caregivers would wish. It is also 
clear that while endoscopy is an excellent tool for diagnosing celiac disease, serologic testing is 
clearly easier, safer and very effective in its predictive value (3); while also useful in monitoring 
the adherence to dietary restrictions. 
It is my hope that more clinicians will consider serologic testing of asymptomatic 
individuals who are at high risk for developing celiac disease (e.g. family history, Down 
syndrome, Turner syndrome) as well as individuals who present with neuropsychiatric symptoms 
such as ADHD, depression or migraine when there is any evidence of GI comorbidity in the 
hopes of preventing the more dangerous complications of celiac disease (e.g. malignancy) and 
more accurately treating the cause of their symptoms. As there is evidence that many of the 
symptoms (inclusive of some neuropsychiatric symptoms) of celiac disease are reversible with 
the initiation of a gluten free diet hopefully the earlier diagnosis of celiac disease will provide a 




The pediatrician should be aware that the exact prevalence and range of neuropsychiatric 
manifestations in the pediatric population is not clearly established. However because of the fair 
reliability of serologic testing, initial screening can be done without the need of GI referral or the 
risks of endoscopy. 
Many clinicians would argue against treating through diet those individuals with 
“potential” celiac disease (serologic evidence but no histologic evidence of disease) but I would 
consider it. Firstly, the neuropsychiatric symptoms experienced by those with celiac disease are 
most likely not from antibodies damaging the gut but from those same antibodies doing damage 
to the nervous system. Decreasing those antibody levels could potentially save the “potential” 
celiac patient from becoming an active celiac patient and spare the nervous system from the 
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